CSIMarket


Compass Therapeutics Inc   (CMPX)
Other Ticker:  
 


 

Compass Therapeutics Inc

CMPX's Financial Statements and Analysis



Compass Therapeutics Inc reported II. Quarter net loss per share of $-1.07 compare to earnings per share of $0.00 in the same quarter a year ago a decrease compare to $-0.14 realized in previous quarter.


II. Quarter
Earnings Per Share Revenues
$ -1.07 $  0 Mill
$-1.07     Unch.    



Compass Therapeutics Inc 's Revenue rose by 0 % in II. Quarter (Jun 30 2021) year on year, to $0 million and declined by sequentially.


Compass Therapeutics Inc is Expected to report next financial results on March 04, 2022.

More on CMPX's Income Statement



Compass Therapeutics Inc 's in II. Quarter recorded net loss of $-56 million, a decrease compare to net income of $0 million achieved in a year ago.

Sequentially net loss advanced

More on CMPX's Growth

In II. Quarter company's net cash and cash equivalents decreased by $-8 million, capital expenditures fell by 0.00%, to $-0 millions compare to same quarter a year ago and fell by 131.25% from I. Quarter (Mar 31 2021).

More on CMPX's Cash flow Statement


Compass Therapeutics Inc does not pay out common stock dividend.

In trailing twelve-month period Compass Therapeutics Inc payed $ -0.74 cash per share, on a free-cash flow basis .

Book value fell by -14.73 % sequentially to $0.56 per share, -4.43% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 0.56 per share from $ 0.65.

Company issued 0.60 million shares or 1.17 % in II. Quarter.


More on CMPX's Dividends

 Market Capitalization (Millions) 166
 Shares Outstanding (Millions) 52
 Total Debt (Millions $) 6
 Revenue (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -93
 Cash Flow (TTM) (Millions $) 6
 Capital Exp. (TTM) (Millions $) -1
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -




Compass Therapeutics Inc does not pay out common stock dividend.

In trailing twelve-month period Compass Therapeutics Inc payed $ -0.74 cash per share, on a free-cash flow basis .

Book value fell by -14.73 % sequentially to $0.56 per share, -4.43% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 0.56 per share from $ 0.65.

Company issued 0.60 million shares or 1.17 % in II. Quarter.


More on CMPX's Balance Sheets

 Market Capitalization (Millions) 166
 Shares Outstanding (Millions) 52
 Total Debt (Millions $) 6
 Revenue (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -93
 Cash Flow (TTM) (Millions $) 6
 Capital Exp. (TTM) (Millions $) -1
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -


   



       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

TIBURON's Profile

Stock Price

TIBURON's Financials

Business Description

Fundamentals

Charts & Quotes

TIBURON's News

Suppliers

TIBURON's Competitors

Customers & Markets

Economic Indicators

TIBURON's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071